NSC 228155

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2955

CAS [113104-25-9]

MF C11H6N4O4S
MW 290.25

Purity: 98%
Soluble in DMSO

NSC 228155

Description

EGFR activator. Furthermore, NSC 228155 was identified as a potent inhibitor of KIX-KID interaction with an IC50 value of 0.36 µM.

F Xie et al. Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5371-5.

V Sakanyan et al. Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells. Sci Rep. 2014 Feb 5;4:3977.

Sakanyan V, et al. Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1. Sci Rep. 2016 Feb 17;6:21088.

Cell Signaling & Oncology EGFR JAK-STAT RTK class I; EC 2.7.10.1

EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction

Chemical name

2-(7-Nitrobenzo[c][1,2,5]oxadiazol-4-ylthio)pyridine 1-oxide

Parent CAS No.

[113104-25-9]

Order

Size	Unit Price	Stock
10 mg	€75.00	In Stock
50 mg	€225.00	In Stock

Need more? Bulk Inquiry

Related Products

Axon ID	Name	Description	From price
1128	Erlotinib hydrochloride	EGFR tyrosine kinase inhibitor		€70.00
1393	Gefitinib	EGFR tyrosine kinase inhibitor		€70.00
1395	Lapatinib ditosylate	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€80.00
1411	Vandetanib	VEGFR and EGFR tyrosine kinase inhibitor		€50.00
1433	CI 1033	EGFR tyrosine kinase inhibitor		€60.00
1506	WZ 4002	EGFR kinase inhibitor (T790M specific)		€70.00
1526	Neratinib	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€80.00
1544	BIBW 2992	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€50.00
1632	OSI 420	EGFR tyrosine kinase inhibitor		€90.00
1653	AEE 788	EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor		€80.00
1665	Pelitinib	EGFR tyrosine kinase inhibitor		€90.00
1760	EGFR Inhibitor [879127-07-8]	Highly selective EGFR tyrosine kinase inhibitor		€120.00
1986	AST 1306 tosylate	ErbB2 and EGFR inhibitor		€90.00
2342	AZD9291	Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs		€95.00
2563	AZD3759	Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor		€85.00
2680	EAI045	Allosteric EGFR inhibitor (L858R/T790M-specific)		€105.00
2920	Poziotinib	Irreversible pan-HER inhibitor		€95.00
3040	Abivertinib	Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs		€95.00
3192	EMI48	Inhibitor of EGFR triple mutants		€120.00
3232	TAK-788	Potent and selective EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€70.00
3235	Dacomitinib	Potent irreversible pan-HER inhibitor		€60.00
3802	TAS6417	EGFR inhibitor		Inquire
3853	BMS-599626	Potent and selective EGFR and ErbB2 inhibitor		Inquire
3862	BGB-283	Orally available dual RAF kinase/EGFR inhibitor		Inquire
4074	AZ5104	EGFR inhibitor		Inquire
4138	CUDC-101	Potent HDAC, EGFR, and HER2 inhibitor		Inquire
4130	PELI1/EGFR disruptor S62	Potent PELI1/EGFR disruptor	Recently added	€130.00

Customer Support

Customer Services

About Axon Medchem

Contact Us

NSC 228155

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

NSC 228155

Description

Chemical name

Parent CAS No.

Related Products

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us